1 / 10

Industry’s Response to Concerns of Academic Medical Centers

Industry’s Response to Concerns of Academic Medical Centers. Joseph S. Camardo, M.D. Senior Vice President CTSA Workshop June 22, 2009. A Twenty Year View of Clinical Research.

takoda
Download Presentation

Industry’s Response to Concerns of Academic Medical Centers

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Industry’s Response to Concerns of Academic Medical Centers Joseph S. Camardo, M.D. Senior Vice President CTSA Workshop June 22, 2009

  2. A Twenty Year View of Clinical Research • Expansion from exclusive involvement of Academic Medical Centers (AMCs) to combined involvement of AMCs and private physician practices • Expansion from the U.S. to the rest of the world • A change from simple clinical research agreements to more complex contracts • Better methodology for clinical trials • An increase in the time and cost of clinical research • A variety of excellent clinical studies and some real advances in medicine

  3. Expanded Complexity of Clinical Contracts • Clinical trials have expanded in scope and complexity resulting in more detailed and complex clinical contracts • More complex contracts require greater review time and a greater amount of resources dedicated to finalizing such contracts • Contracts often include multiple parties • Certain issues have become more heavily negotiated because of policy changes or current risk evaluation • Indemnification • Subject Injury • Insurance • Intellectual Property

  4. Globalization and Standardization: A Process Change to Increase Efficiency • Global studies demand global standardization • Objective: global standards for contracting • Standardized study kick-off meeting process • Standardized global tools • Agenda • Kick-off meeting questions • Contracting plan • Creation of a global eRoom to house templates • Global access with Wyeth login

  5. Academic Medical Centers and Industry Have Similar Concerns About Clinical Research • Access to decision makers • Changing policies and contract templates • Master agreements and previously negotiated agreements • Lack of understanding of academic mission • Priority given to sites that do not negotiate agreements • Complex process of contracting within industry

  6. Academic Medical Centers and Industry Have Similar Concerns About Clinical Research • Access to decision makers • Sites work directly with individuals who have decision making authority over the contract and budget • For issues that fall outside of company policy, a committee of executives (VPs) meet weekly to make final decisions • Medical, legal and contract staff are always available to sites • Changing policies and contract templates • Very infrequent – this may differ from company to company • Templates and internal policies evolve on an on-going basis and changes are a result of outside influences • legal or regulatory change • greater oversight and scrutiny of industry • change in risk evaluation

  7. Academic Medical Centers and Industry Have Similar Concerns About Clinical Research • Unwillingness to abide by master agreements or previously negotiated agreements • Case by case consideration depending on type and phase of study • May need more IP protection for Phase 2 versus Phase 4 • Risk evaluations depend on type of study, scope and procedures • AMCs often ask for study specific contract terms • Often require changes to master agreements • A policy change may require a change to the MSA • Lack of understanding of academic mission • Industry sponsored research different from academic research • Large scale clinical trials are time sensitive and goal directed • In general, each AMC is providing only a small part of the enrollment for any study, supported by the company funds

  8. Academic Medical Centers and Industry Have Similar Concerns About Clinical Research • Priority attention given to sites that do not negotiate agreements • Smaller organizations (community hospitals, private practices, commercial research facilities) tend to negotiate less so contracts can be finalized and signed more rapidly • Study start-up and enrollment always under time pressures • AMCs have more layers of internal review • Less flexibility on contract negotiations: IP, budget • Often third party study sites involved • Master Agreements can address some issues, but there are no master budgets • Complex process of contracting within industry • Streamlined process and appropriate staff to handle legal and budget negotiations and administration of contracts • Contracting not frequently outsourced • Standard process followed across all therapy areas and most regions

  9. How Can Academic Medical Centers Mission For Research Meet Industry Mission For Development? • When do we shift from R to D? • Is the AMC a Phase 2 not a Phase 3 site? • How can we improve protocol development? • Is there a new way to execute the industry sponsored study? • How can we make it easier and more efficient? • Can study start timelines be shortened? • Can costs be reduced? • Is a country-wide master agreement possible?

  10. Industry’s Response to Concerns of Academic Medical Centers Joseph S. Camardo, M.D. Senior Vice President CTSA Workshop June 22, 2009

More Related